Additionally, nuclear localization of the insulin-like growth factor-1 receptor (nIGF-1R) in tumor cells is emerging as a potentially vital factor in tumor pathophysiology and has been linked to adverse clinical outcomes in various cancers [44,45]. Here, IGF1R is linked to neoplasm.